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Abstract
Background
DNA repair mechanisms are crucial for maintenance of the genome in all organisms, includ-
ing parasites where successful infection is dependent both on genomic stability and
sequence variation. MSH2 is an early acting, central component of the Mismatch Repair
(MMR) pathway, which is responsible for the recognition and correction of base mismatches
that occur during DNA replication and recombination. In addition, recent evidence suggests
that MSH2 might also play an important, but poorly understood, role in responding to oxida-
tive damage in both African and American trypanosomes.
Methodology/Principal Findings
To investigate the involvement of MMR in the oxidative stress response, null mutants of
MSH2 were generated in Trypanosoma brucei procyclic forms and in Trypanosoma cruzi
epimastigote forms. Unexpectedly, theMSH2 null mutants showed increased resistance to
H2O2 exposure when compared with wild type cells, a phenotype distinct from the previ-
ously observed increased sensitivity of T. brucei bloodstream formsMSH2mutants. Com-
plementation studies indicated that the increased oxidative resistance of procyclic T. brucei
was due to adaptation to MSH2 loss. In both parasites, loss of MSH2 was shown to result in
increased tolerance to alkylation by MNNG and increased accumulation of 8-oxo-guanine
in the nuclear and mitochondrial genomes, indicating impaired MMR. In T. cruzi, loss of
MSH2 also increases the parasite capacity to survive within host macrophages.
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Conclusions/Significance
Taken together, these results indicate MSH2 displays conserved, dual roles in MMR and in
the response to oxidative stress. Loss of the latter function results in life cycle dependent dif-
ferences in phenotypic outcomes in T. brucei MSH2mutants, most likely because of the
greater burden of oxidative stress in the insect stage of the parasite.
Author Summary
Trypanosoma brucei and Trypanosoma cruzi are protozoa parasites that cause sleeping
sickness and Chagas disease, respectively, two neglected tropical diseases endemic in sub-
Saharan Africa and Latin America. The high genetic diversity found in the T. cruzi popula-
tion and the highly diverse repertoire of surface glycoprotein genes found in T. brucei are
crucial factors that ensure a successful infection in their hosts. Besides responding to host
immune responses, these parasites must deal with various sources of oxidative stress that
can cause DNA damage. Thus, by determining the right balance between genomic stability
and genetic variation, DNA repair pathways have a big impact in the ability of these para-
sites to maintain infection. This study is focused on the role of a DNA mismatch repair
(MMR) protein named MSH2 in protecting these parasites’DNA against oxidative assault.
Using knock-out mutants, we showed that, besides acting in the MMR pathway as a key
protein that recognizes and repairs base mismatches, insertions or deletions that can occur
after DNA replication, MSH2 has an additional role in the oxidative stress response.
Importantly, this extra role of MSH2 seems to be independent of other MMR components
and dependent on the parasite developmental stage.
Introduction
Two members of the trypanosomatidae family, Trypanosoma cruzi and Trypanosoma brucei,
are important human pathogens, since they cause, respectively, Chagas disease, or American
trypanosomiasis, and African Sleeping Sickness, or Human African trypanosomiasis. Together,
T. cruzi and T. brucei infections affect almost 20 million people [1, 2]. The life cycles of both
these parasites involve two hosts: an invertebrate vector and a mammalian host. In the digestive
tract of the insect vector T. cruzimultiplies as epimastigotes and differentiates into metacyclic
trypomastigotes, which are expelled with the vector’s faeces. After a blood meal, trypomasti-
gotes injected in the host bloodstream can invade different cell types, where they replicate as
intracellular amastigotes that, after a number of replication cycles in the host cell cytoplasm,
differentiate into trypomastigotes and lyse the host cell membrane. Despite being similar in
general strategy, the life cycle of T. brucei is different to that of T. cruzi in several key details.
Notably, T. brucei does not display any intracellular replicative stages. In the mammal, T. bru-
cei is exclusively extracellular, replicating in the bloodstream and tissue fluids as bloodstream
form (BSF) cells, which can be taken up by the tsetse fly vector during a bloodmeal. In the
insect vector BSF cells differentiate into replicative procyclic forms (PCF), which then undergo
several further differentiation events associated with migration to the fly salivary glands, where
non-replicative metacyclic trypomastigotes are formed and can be passed into a new mamma-
lian host through the proboscis when the infected fly is feeding [3]. Irrespective of the detailed
differences in the life cycles, differentiation between the mammal-infective and vector-infective
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forms of both T. cruzi and T. brucei is accompanied by dramatic metabolic changes and mor-
phological alterations [4].
The ability to multiply and survive inside a host or vector is crucial for the maintenance of a
parasite infection and transmission, allowing continuation of the life cycle. As for any cell, uni-
cellular parasites are exposed to potentially deleterious events during cell division. The by-
products of cellular metabolism, allied to routine errors during DNA replication or recombina-
tion processes, represent endogenous sources of potential DNA damage and genome change.
In addition, all organisms are subjected to exogenous genotoxic agents from the environment
or, in the case of parasites, derived from host. In the mammalian host, T. cruzi invades non-
phagocytic cells or can be internalized by macrophages by a phagocytosis-like process [5].
Inside macrophages T. cruzi triggers the activation of NADPH oxidase, which generates large
amounts of reactive oxygen species (ROS) such as O2⠁
-. Moreover, pro-inflammatory cytokines
triggered by T. cruzi infection also stimulate infected macrophages to produce high amounts of
nitric oxide (⠁NO) through the induction of inducible nitric oxide synthase (iNOS), which can
react with O2⠁
- producing peroxynitrite (ONOO-), a powerful oxidant and cytotoxic molecule
[6, 7]. Similarly, the insect life forms of both parasites must also deal with the invertebrate oxi-
dative stress response generated against the parasite. Upon challenge with T. brucei the tsetse
fly activates iNOS, generating ⠁NO, and increases the levels of ROS such as hydrogen peroxide
(H2O2) [8, 9]. To deal with all of these potentially genome damaging agents, trypanosomes,
like any other organism, possess multiple DNA repair pathways [10, 11], though little work has
detailed to what extent these pathways are needed in different parasite life cycle stages. One
such DNA repair pathway is Mismatch Repair (MMR), which acts to detect and correct mis-
paired bases that escape the proofreading activity of DNA polymerases during replication or
occur during recombination between non-identical DNAmolecules. In eukaryotic cells, even
small distortions in DNA caused by single-base mismatches or insertion/ deletion loops (IDLs)
of 1–3 bases are recognised by the “sliding clamp” heterodimer formed by MSH2 and MSH6
proteins, which moves along DNA searching for errors [12]. Larger IDLs are recognised by a
distinct heterodimer, composed of MSH2 and MSH3. Eukaryotes encode several further MSH
proteins, all of which are homologous to bacterial MutS proteins, though many have adopted
non-MMR roles [13]. Following mismatch recognition, an ATP-dependent conformation
change in MSH2-6 or MSH2-3 promotes interaction with heterodimeric homologues of bacte-
rial MutL proteins, bringing these factors to the site of the lesion. The excision step is catalyzed
by an endonuclease activity within the MutL-related heterodimer formed between MLH1-
PMS1 [14], and that activity is activated by PCNA (a component of replication machinery)
[15] [16]. A defect in or directed inactivation of the MMR pathway leads to a 100–1000 fold
increase in spontaneous mutation rate in all organisms examined, including Escherichia coli
[17], Saccharomyces cerevisiae [18], Caenorhabditis elegans [19, 20], and T. brucei [21]. In
human cells and murine models MMR deficiency is correlated with predisposition to cancer
[22, 23]. MMR suppresses mutations by increasing DNA replication fidelity through prevent-
ing base substitutions or repeat sequence instability, events that can also occur during homolo-
gous recombination [24].
In addition to repair of non-identical DNA sequences, MMR has also been demonstrated
to be involved in the response to DNA damage induced by genotoxic agents, among them the
alkylator N-methyl-N’-nitro-N-nitrosoguanidine (MNNG), the anti-cancer drug cisplatin
and H2O2 [25]. Methylation of DNA by MNNG gives rise to O
6-methylguanine (O6-MeG),
opposite which thymine can be misincorporated during replication, forming a base mismatch
recognised by MMR. Defective MMR is associated with increased tolerance to MMNG [26],
due to loss of what has been termed a futile cycle of repair, where MMR fails to remove O6-
MeG and instead re-inserts either cytosine or thymine opposite the lesion. In some
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organisms, active MMR at MNNG damage leads to persistent DNA breaks and increased cell
death [27]. H2O2 generates reactive oxygen species (ROS) with high capacity to damage DNA
[28]. The most common DNA lesion resulting from ROS is 7,8-dihydro-8-oxoguanine
(8-oxoG) [29]. MMR has the ability to prevent oxidative mutagenesis in E. coli by removing
8-oxoG or adenine misincorporated paired with 8-oxoG [30]. In S. cerevisiae it was demon-
strated that the MSH2-MSH6 heterodimer has a direct role in removing adenine in 8-oxoG:A
mispaired bases [31]. More recently, Zlatanou et al. proposed a non-MMR role for MSH2-
MSH6 in human fibroblasts in response to oxidative damage. The model suggests that in
some circumstances DNA oxidative damage by MSH2-MSH6 does not recruit other MMR
proteins, but instead repair is mediated through the action of monoubiquinated-PCNA
(mUb-PCNA) and Polη [32].
With the availability of the complete genome sequences of T. brucei and T. cruzi the full rep-
ertoire of the parasite’s putative DNAMMRmachinery was revealed to comprise homologues
of MSH2, MSH3, MSH6 (originally named MSH8) [21], MLH1 and PMS1 [10, 33, 34]. How-
ever, functional characterization studies to date have been limited to a single life cycle stage in
each parasite and have only tested the roles of MSH2 in T. brucei and T. cruzi, and MLH1 in T.
brucei. Null mutants of T. brucei msh2 (Tbmsh2-/-) ormlh1 (Tbmlh1-/-) in BSF cells show sev-
eral phenotypes characteristic of MMR-deficient cell lines: increased tolerance to MNNG,
increased rates of sequence change in a number of microsatellite repeat loci, and elevated rates
of homologous recombination-based integration of transformed DNAmolecules carrying base
mismatches relative to genomic target loci [21, 35, 36]. In addition, evidence that TbMSH2 and
TcMSH2 play a role in in the oxidative stress response has been found in studies showing that
Tbmsh2-/- BSF cells and Tcmsh2+/- epimastigotes are more susceptible to H2O2 treatment
than wild type parasites [21, 37]. The role played by MSH2 in tackling oxidative damage
appears not to involve a complete MMR reaction, since BSF Tbmlh1-/-mutants do not display
equivalent increased H2O2 sensitivity to Tbmsh2-/- mutants [38]. Moreover, heterologous
expression of T. cruziMSH2 in T. brucei msh2-/- mutants shows that the American trypano-
some MSH2 protein can functionally replace the endogenous MSH2 protein in the oxidative
stress response, but cannot work with the T. bruceiMMRmachinery to successfully execute
MMR [38]. Although only single allele knock-outs ofmsh2 have been described in T. cruzi epi-
mastigotes, the T. cruzimsh2+/- mutants display increased sensitivity to H2O2 treatment [37],
consistent with the null mutants in T. brucei BSF cells [38]. However, despite evidence in both
T. brucei and T. cruzi that H2O2-induced damage predominantly affects the kinetoplast
genome when MSH2 is lost or impaired [37], the exact role of MSH2 remains elusive. Here, we
have sought to clarify the role of MSH2 in the oxidative stress response of T. brucei and T.
cruzi, and to ask to what extent this putative MMR-related function is conserved or diverged in
the two parasites. We describe the generation ofmsh2 null mutants in T. brucei PCF cells,
which differ from BSF cells in the increased use of mitochondrial metabolism [39], with the
consequence that there is greater endogenous reactive oxygen species. In addition, we describe,
for the first time, the generation ofmsh2 null mutants in T. cruzi epimastigote cells, which also
rely on aerobic metabolism [40]. In both cell types,msh2 null mutants are viable and are
impaired in MMR. Unexpectedly, both mutants do not display increased sensitivity to H2O2
treatment, but instead, increased resistance, which we suggest to be due to parasite adaptation
to the loss of a crucial molecule. Thus, we propose that MSH2 provides one of several intercon-
nected mechanisms that are common to T. brucei and T. cruzi and allow both parasites to cope
with oxidative stress.
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Methods
Parasite cultures
T. brucei cultures of the Lister 427 strain were maintained as both bloodstream (BSF) and pro-
cyclic (PCF) forms. BSF parasites were maintained at 37°C, 5% CO2 in HMI-9 (GIBCO)
medium supplemented with 20% fetal bovine serum (GIBCO). Cell passages were performed
every 48 hours, with population density maintained between 1 x 105 and 2 x 106 cells.mL-1.
PCF cells were maintained at 27°C in SDM-79 (GIBCO) medium supplemented with 10% fetal
bovine serum (GIBCO). Weekly passages were performed, but cell density was never lower
than than 5 x 105 cells.mL-1.
Epimastigote forms of the CL Brener clone of T. cruzi were maintained in logarithmic
growth phase at 28°C in liver infusion tryptose (LIT) medium supplemented with 10% fetal
bovine serum (GIBCO) and penicillin (10,000 U.mL-1)/Streptomycin (10,000 μg.mL-1)
(GIBCO) as described by [41]. Metacyclic trypomastigotes, obtained after metacyclogenesis of
epimastigotes cultures maintained in LIT medium for 15 to 20 days, were used to infect Vero
cells cultured in DMEMmedium (GIBCO) supplemented with 5% fetal bovine serum
(GIBCO).
Parasite transfections
Transfection of PCF parasites were carried out at a density of 5 x106 cells.mL-1 resuspended in
0.5 mL of ice-cold Zimmerman medium (132 mMNaCl, 8 mM KCl, 8 mM Na2HPO4, 1.5 mM
KH2PO4, 0.5 mMMgAc2, and 0.06 mM CaAc2, pH 7.5) and 10 μg of DNA. The mixture was
subjected to two rounds of electroporation with a Bio-Rad Gene Pulser II (1.5 kV current and
25 μF capacitance). The cells were then transferred into SDM79 medium and incubated at
27°C overnight. To select for antibiotic-resistant transfectants, parasites were diluted 1:100 and
1:10 in 96 well plates containing conditioned medium and the appropriate antibiotic and incu-
bated for 10–14 days.
Transfection of BSF cells were carried out using AMAXA Nucleofactor (Amaxa Biosys-
tems) with 4 x 107 cells resuspended in 100 μL of nucleofector solution (optimised for
human T-cells) and mixed with 5–10 μg of DNA. After following the nucleofection protocol
according to manufacturer instructions, the cells were serially diluted 1:10, 1:100 and 1:1000
in HMI-9 medium without antibiotic and incubated 6–12 hrs for recovery, after which 1 mL
of HMI-9 medium containing antibiotic was added to each well. To select forMSH2 or
MLH1 single allele mutants, PCF cells were selected with either 10 μg.mL-1 blasticidin or
1 μg.mL-1 puromycin; both drugs, at the same concentrations, were used to select for dele-
tion of the second allele in the single allele mutants. To select for PCFmsh2-/- cells in
which MSH2 was re-expressed, transformants were grown in the presence of 2.5 μg.mL-1
phleomycin.
Transfection of T. cruzi epimastigotes was carried out with 107 cells.mL-1 collected during
exponential growth phase and 100 μg of plasmid constructions as previously described [42].
Twenty-four hours after transfecting hygromycin resistant cell lines, 100 μg.mL-1 of selective
antibiotic (G-418 Sulfate) was added to transfected cultures. Weekly passages were performed
with increasing concentration of the selective drug (up to 200 μg.mL-1). After 30–40 days, a
double-resistant population was selected and cloned cell lines were obtained by plating epimas-
tigotes on semisolid blood agarose plates with 200 μg.mL-1 of G-418 Sulfate and Hygromycin
B, after an additional 30 days of incubation at 28°C.
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Plasmid constructs to generate knockout parasites, MSH2 re-
expressers and to inhibit msh2 expression by RNAi
Knockout constructs to deletemsh2 (TritrypDB Tb927.10.11020) ormlh1 (TritrypDB
Tb927.8.6840) in T. brucei PCF cells have been described before [21] and were generated by
PCR-amplifying the 5’ and 3’ UTRs corresponding to each gene from TREU 927 genomic
DNA and cloning into pBluescript II KS and separated by antibiotic resistance gene (BSD and/
or PUR), flanked by 230 bp of β-α tubulin and 330 bp of α-β tubulin processing signals. The
constructs were linearized by digestion with XhoI and NotI restriction enzymes before trans-
fecting into T. brucei PCF.
Epimastigote cultures of T. cruzi with one of themsh2 alleles disrupted by a Hygromycin
resistance gene was generated as described by [37]. The deletion of the second allele was per-
formed using a DNA construct containing the Neomycin phosphotransferase gene (Neo)
flanked by intergenic sequences of theHX1 and GAPDH regions that were PCR-amplified from
the pROCK-GFP vector [42] and cloned into pGEM T-easy vector (Promega). DNA sequence
corresponding to ~500 bp of the 5’ and 3’ end of TcMSH2 (TritrypDB TcCLB.507711.320) cod-
ing region was inserted upstream and downstream ofHX1 and GAPDH, respectively, in the
pTopo_HX1_Neo_GAPDH and the plasmid linearized using the XbaI and SmaI restriction
enzyme digestions before transfection.
T. brucei msh2-/- BSF and PCF were transfected with an MSH2 re-expression construct,
which has been described before [21] and where themsh2 ORF integrates and replaces either
the BSD or PUR resistance cassette in the mutatedmsh2-/- locus. This construct was generated
using a 4.5 kb region containing theMSH2 gene flanked byMSH2 5’UTR and 3’UTR. The 4.5
kb fragment was cloned into pBluescript SK II, followed by a cloned phleomycin resistant cas-
sette downstream of the 3’ UTR of theMSH2 gene. The construct was digested withHindIII
prior to transfection.
To generate RNAi constructs for MSH2, a 513bp region of the gene was PCR-amplified
from wild type Lister 427 genomic DNA and cloned into the vector pZJM [43] where they are
flanked by opposing T7 promoters and Tet operator sequences. The MSH2 RNAi plasmid was
linearized with NotI and used to transform T. brucei PCF strain 427 pLew29-pLew13 developed
by Wirtz et al [44], constitutively co-expressing T7 RNA polymerase and Tet repressor. Clones
were selected with 2.5 μg.ml-1 phleomycin.
RNA extraction, northern blot, cDNA generation, reverse transcriptase
(RT) reaction and quantitative RT-PCR
Total RNA was isolated from T. brucei PCF form and T. cruzi epimastigote forms using the
RNeasy kit (Qiagen). For cDNA generation RNA samples were treated, on column, with
RNAse-free DNAse (Qiagen) as per the manufacturer’s instructions. cDNA was synthesized
using High Capacity RNA-cDNA master mix (Applied Biosystems). cDNA from wild type
(WT) cells, Tbmsh2+/- blasticidin (BSD) or puromycin (PUR) resistant clones, Tbmsh2-/-,
Tbmlh1+/- BSD or PUR resistant clones and Tbmlh1-/- were used in reverse transcriptase (RT)
PCR with specific primers for the TbMSH2 or TbMLH1 genes. As a positive control, primers to
specifically PCR-amplify TbRAD51 were used. For northern blot analyses, 20 μg of total RNA
of T. cruziWT, Tcmsh2+/- and three different clones of Tcmsh2-/- were separated in a 1.2%
agarose/MOPS/formaldehyde gel. The RNA was then transferred to hybond-N+membrane
(GE Healthcare) and hybridized with a TcMSH2 specific PCR fragment previously labelled
with [α-32P]-dCTP using the Amersham Ready-to-Go DNA Labelling Beads (GE Healthcare).
The hybridization was carried out as previously described by [45]; briefly, hybridisation was in
50% formamide buffer overnight at 42°C, after which the blot was washed twice with 2× SSC/
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0.1% SDS at 65°C for 20 min. The membrane was then exposed to a phosphor screen of the
STORM 820 phosphor image (GE Healthcare) and analysed by ImageQuant TL software (GE
Healthcare). To quantify levels of mRNA by RT-PCR after RNAi induction, primers specific
formsh2 andmlh1 genes were used. As a endogenous control primers for GPI8 gene (Tri-
trypDB Tb427.10.13860) were used. SYBR Green PCRMaster Mix (Applied Biosystems) was
used for PCR in 96 well plates. Reactions were run on an ABI Prism 7000 thermocycler and
mRNA levels quantified from amplification according to the manufacturer’s instructions;
Microsatellite instability
T. brucei PCF MMRmutants were tested for genetic instability by PCR amplification of the
region containing the JS-2 microsatellite from parasites grown in the absence or presence of
20 μMH2O2 for 48 hours. The JS-2 microsatellite has been mapped to Chromosome IV and is
composed of GT-dinucleotide repeats [46]. Genomic DNA was extracted from 10 independent
clonal populations derived from PCF wild type and knockout mutants and PCR-amplified
with JS2 microsatellite complementary primers. PCR products were resolved for 50 minutes at
100 V by electrophoresis in a 3% low melting agarose gel.
Treatment with genotoxic agents
Mid-log phase PCF T. brucei cultures were inoculated in SDM-79 (GIBCO) at density of 5 x
105 cells.mL-1 in the absence or presence of 2.5 μM or 5 μMN-methyl-N’-nitro-N-nitrosogua-
nidine (MNNG, Tokyo chemical industry Ltd). After 72 hours survival was determined using a
haematocytometer. T. cruzi epimastigote form cells in the exponential growth phase were
counted and diluted to 1x 107 cells.mL-1 in LIT medium in the absence or presence of 5 μM
MNNG (Tokyo chemical industry Ltd). After 72 hours cell densities were determined by
counting live cells with a haematocytometer using Erythrosin B exclusion.
Mid-log phase T. brucei PCF cells were diluted to 5 x 105 cells.mL-1 in SDM-79 (GIBCO)
and then incubated with 10 μM or 20 μMH2O2 (VWR) at 27°C for 48–72 hours. BSF cells
were diluted to 1 x 106 cells.mL-1 in HMI-9 medium (GIBCO) and incubated with 100 μM or
200 μMH2O2 (VWR) at 37°C, 5% CO2 for 48 hours. After growth, cell density was measured
using a haematocytometer. T. cruzi epimastigote form in exponential growth phase were
diluted to 1x 107 parasites.mL-1 in PBS 1x and incubated with 75 μMH2O2 (Sigma-Aldrich)
for 20 minutes at 28°C. After this, the cells were centrifuged, washed once with PBS and
allowed to recover in LIT medium for 48 hours before cell densities were determined by count-
ing live cells with a haematocytometer using Erythrosin B exclusion.
Cell growth analyses after induction of RNAi
Two clones of PCF RNAi cell line targeting MSH2 were grown to log phase and diluted to a
starting density of 5 x 105 cells.mL-1. Each culture was then split and grown in the absence of
tetracycline or after the addition of tetracycline to 2 μg.mL-1. Cell density was determined
every 24 hours up to 72 hours and then the cultures were diluted to their starting density. After
adding again tetracycline to induce siRNA expression, parasite numbers were further deter-
mined every 24 hours for a further 72 hours, before diluting again the cultures back to starting
densities.
T. cruzi in vitro infection of Vero cells and mouse macrophages
Trypomastigotes released in the supernatants of infected Vero cells were counted with a hae-
mocytometer and an equivalent cell number for each culture was used to infect Vero cells or
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intraperitoneal macrophages (harvested from BALB/c mice) that had been allowed to adhere
to glass cover slips in a 24 well plate. Trypomastigotes were incubated with the cell monolayers
for 4 hours, after which non-internalized trypomastigotes were washed away with PBS 1x. The
infected cells were incubated for an additional 48 hours at 37°C. The number of intracellular
amastigotes was determined by staining cell nuclei with DAPI (1000 μg.mL-1) and visualised
through fluorescence microscopy (Olympus). The average number of amastigotes was deter-
mined from analysing 1000 host cells, in different fields of the microscopy slide.
In vitro infection of BALB/c mice macrophages were carried out in strict accordance with
the Brazilian laws regarding animal use (Law # 11.794, December 8, 2008), following a protocol
approved by the Committee on the Ethics of Animal Experiments of UFMG (CETEA-UFMG)
under the number 132/2014.
8-oxoguanine measurement
8-oxoG measurement was performed based on the principle of binding affinity of FITC-conju-
gated avidin to 8-oxoG [47] and an adapted protocol [48], which has been previously used to
quantify oxidative DNA lesions in different T. cruzi strains and mutants for different DNA
repair proteins [37, 49, 50]. Briefly, 20 μL aliquots of cell suspensions were distributed on a
glass slide coated with poly-lysine (Sigma-Aldrich) and left to adhere for 5–10 min, after which
cells were fixed with ice-cold methanol for 20 min at -20°C. The methanol-fixed cells were then
washed with room temperature PBS 1x, cells permeabilized with 0.1% Triton X-100 for 3 min
and incubated with RNase A (100 μg.mL-1) for 1 hour at 37°C. After another wash with PBS
1x, cells were treated with proteinase K (10 μg.mL-1) for 7 min at room temperature, followed
by treatment with HCl (4N) for 7 min at room temperature and overnight blocking with 10%
fetal bovine serum. FITC-avidin was diluted 1:200 in blocking buffer and incubated with the
cells for 1 hour at room temperature. After extensive washing with PBS, cell nucleus and
kDNA were stained with DAPI. Slides were mounted with prolong gold anti-fade solution
(Molecular Probes/Life Technologies), visualized under a fluorescence microscope and images
of at least 10 different fields were captured. After manually delimiting the nucleus and the
kDNA of each parasite, as visualized by DAPI staining, FITC- fluorescence intensity restricted
to these sites were determined with ImageJ software and plotted as the average fluorescence
(arbitrary units) of 100 random cells.
Epitope tagging MSH2
T. brucei BSF, PCF and T. cruzi epimastigote cells were transfected with constructs to tag
MSH2 C-terminally in the endogenous locus. Primers were generated against a C-terminal
region ofmsh2ORF, but excluding the stop codon. The region was selected to have a unique
restriction enzyme recognition site within the ORF fragment that could be used to linearize the
DNA. This fragment was cloned into the plasmid pNAT12myc [51] allowing in frame fusion of
the ORF with 12 repeats of the c-MYC epitope. Similarly, the C-terminal region of Tcmsh2
ORF was cloned in pCR 2.1 Topo vector (Life Technologies) in frame with the 12 repeats of the
c-MYC epitope derived from the T. brucei pNAT12myc plasmid. As a selective mark, neomycin
resistance gene derived from the pROCK_Neo plasmid [42] was also cloned in the same pCR
2.1 Topo vector. The constructs were linearized with BmgBI (for T. brucei) or SalI (for T. cruzi)
restriction enzymes and used to transfect heterozygousmsh2 knockout mutants of T. brucei,
and wild type T. cruzi epimastigotes; transfected T. brucei or T. cruzi were selected with 10 μg.
mL-1 blasticidin or 200 μg.mL-1 G418 Sulfate, respectively.
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Cellular localization
T. brucei BSF and PCF expressing MSH2 fused to 12x c-MYC epitopes were fixed in chilled
methanol for 1 hour or overnight. Fixed slides were then blocked with 2% fetal calf serum
(FCS), incubated with mouse anti-c-MYC antiserum (1:5000) (Millipore) for 1 hour, followed
by incubation with Alexafluor 594 conjugated anti-mouse IgG secondary antiserum (Molecular
Probes/ Life Technologies) in the dark. Slides were mounted with vectashield containing
4’,6-diamidino-2-phenylindole (DAPI; Vector labs) and visualized on a Zeiss Axioplan micro-
scope. Images were captured using Hamamatsu ORCA-ER digital camera and Openlab soft-
ware. T. cruzi epimastigote and amastigote cells expressing MSH2 fused to 12x c-MYC
epitopes were fixed with 4% paraformaldehyde for 5 minutes, permeabilized with 0.1% Triton
X-100 for 10 min, blocked with 1% BSA, 0.2% Tween 20 for 1 hour at room temperature and
incubated with 1:500 anti-c-MYC antiserum conjugated to Alexa 488 (Milipore) for 1 hour.
After washing with PBS, nuclei were stained with 1 μg.mL-1 of DAPI (Molecular Probes/ Life
Technologies) for 5 min and cover slides mounted with prolong gold anti-fade solution
(Molecular Probes/ Life Technologies). Images were captured on an Olympus BX60 micro-
scope using Q-color 5 digital camera and Qcapture Pro 6.0 software.
Statistical analysis
Statistical analyses in this work were performed using GraphPad Prism version 5.00 (GraphPad
Software, San Diego California USA). Data are presented as mean plus standard deviation, and
all experiments were repeated at least three times. Results were analysed for significant differ-
ences using ANOVA followed by Bonferroni post-test. Statistical tests used are described at
each figure legend. The level of significance was set at P< 0.05.
Results
T. brucei procyclic form and T. cruzi epimastigotemsh2 null mutants
have increased resistance to oxidative stress
The genomes of T. brucei and T. cruzi each contain a single-copy gene encoding MSH2 [33,
34]. To generate T. brucei PCFmsh2 null (-/-) mutants, we relied upon the same constructs
used previously to make BSF cells in which bothmsh2 alleles were deleted [21] (S1 Fig). In par-
allel, we also generated T. brucei PCFmlh1-/- mutants, again using pre-existing constructs. For
both genes, the constructs replace the entire ORF (2856 bp and 2664 bp forMSH2 andMLH1,
respectively) after homologous integration. Cells with a single allele deleted (heterozygous
mutants; +/-) were first selected using either a construct encoding resistance to blasticidin
(BSD) or puromycin (PUR) and confirmed by PCR (S2 Fig). The +/- cells were then trans-
formed with the reciprocal construct to attempt to make-/- mutants lacking both alleles; in
both cases, and for reasons that are unclear, this was only successful when transforming the
PUR deletion constructs into the cells that had integrated BSD and, furthermore, required a
number of transformation attempts using varying antibiotic selection concentrations. Correct
integration of the constructs and loss of both TbMSH2 or TbMLH1 alleles in the-/- mutants
were confirmed by PCR (S2 Fig). Deletion of both alleles in the PCF-/- mutants was further
verified by RT-PCR amplification of RNA extracted from drug resistant parasites: as shown in
Fig 1A, PCR products from the ORFs were detected in +/- cells as well as in wild type (WT)
parasites, but not in the-/-mutants.
To generate T. cruzi epimastigotemsh2-/- mutants, we started with clones in which one
MSH2 allele was deleted (+/- cells) [37] and replaced by the ORF for the hygromycin phospho-
transferase (HYG) gene. It should be noted that in themsh2 heterozygous mutants (+/-) the
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HYGmRNA is generated by the predicted 5’ and 3’ processing signals flanking theMSH2 gene.
In order to mutate the remaining allele, we found it was necessary to use a gene disruption con-
struct (S1 Fig) in which a neomycin phosphotransferase gene ORF (NEO) was flanked
upstream by processing signals derived from the T. cruzi intergenic region of the TcP2β gene
[52], and downstream by the intergenic region derived from the gapdh gene [42]. To allow inte-
gration into the remainingMSH2 allele, homologous targeting was based on TcMSH2 ORF
sequence, and not on the 5’ and 3’UTRs, as used before to generate themsh2+/- mutants.
Fig 1. Generation of mismatch repair null mutants in T. cruzi and T. brucei. (A) Agarose gel electrophoresis of reverse transcriptase (RT) PCR products
to verify the absence ofMSH2 orMLH1mRNA in T. brucei procyclic form mutants. cDNA derived from wild type (WT) cells, blasticidin (BSD) or puromycin
(PUR) resistant clones of Tbmsh2 single allele knockouts (+/-) and Tbmsh2 double allele knockouts (-/-) were PCR-amplified withMSH2 orMLH1- specific
primers; the size of the PCR product is indicated and a control reaction without cDNA is indicated by C. The bottom panel shows, as positive controls, cDNAs
from the same cells PCR-amplified (RT+) with primers specific for the RAD51 gene; a control for genomic DNA contamination, in which reverse transcriptase
was excluded from the cDNA synthesis reaction (indicated by RT-) is also shown. (B) Total RNA extracted from T. cruzi epimastigote form wild type (WT)
cells, a Tcmsh2 single allele knockout (+/-) mutant and three independent clones of Tcmsh2 double allele knockouts (-/-) were transferred to a nylon
membrane and hybridized with [α-32P]-labeled probe specific for the T. cruzi MSH2 gene. The bottom panel shows hybridization with a probe for 24Sα rRNA,
used as loading control.
doi:10.1371/journal.pntd.0003870.g001
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Finally, in order to successfully select for-/- cells, in which the first allele was deleted and the
second disrupted, transformed parasites had to be selected initially with a low drug concentra-
tion (100 μg.mL-1) that was gradually increased to 150 μg.mL-1 and 200 μg.mL-1 during a
period of 4 weeks. PCR amplification of DNA extracted from the Tcmsh2+/- cells, and from
three cloned putative Tcmsh2-/- cell lines showed the expected integration of the different
MSH2 targeting constructs in the T. cruzi genome (S1 Fig). Northern blots using a probe spe-
cific for the TcMSH2 ORF and for the 24Sα rRNA as a loading control showed 52% less
TcMSH2mRNA in the +/- cells relative to WT, and no detectableMSH2mRNA in the
Tcmsh2-/- clones (Fig 1B), confirming the gene disruption. The apparent reduction in TcMSH2
mRNA levels in the +/- cells is consistent with the observation of altered phenotypes in these
cells relative to WT (see below; and [37]). Similar to T. brucei msh2mutants, no changes in
population doubling times were detected when comparing growth of WT cells to the T. cruzi
mutants with one or bothmsh2 alleles deleted (S3 Fig).
To ask if the mutations described above result in detectable loss of MMR, we measured the
sensitivity of the parasites to MNNG [26]. T. brucei and T. cruzimutants and WT cells were
grown for 72 hours with increasing concentrations of MMNG. Survival of the cells was deter-
mined by measuring the cell density of the WT or mutant cells after MNNG treatment relative
to untreated cells. In T. brucei, all cells showed increasing growth impairment as MNNG was
increased from 2.5 to 5 μM. However, similar to what has been described in BSF cells [21], and
consistent with the proposed futile cycle of alkylation repair in MMR-proficient cells [26, 27],
deletion of one allele of Tbmsh2 or Tbmlh1 in the PCF+/- mutants caused increased tolerance
to MNNG, and this tolerance increased yet further when both alleles were deleted in the-/-
mutants (Fig 2A). Deletion of TbMSH2 or TbMLH1 in PCF cells also resulted in the-/- para-
sites displaying increased microsatellite instability, as was observed in T. brucei BSF mutants,
indicating decreased replication fidelity (S4 Fig). In T. cruzi increased tolerance to 5 μM
MNNG was seen in the Tcmsh2+/- cells and was not detectably increased in the-/- mutants
(Fig 2B). Though this somewhat contrasts with the response of T. bruceiMMRmutants to
MNNG, these data nonetheless show that mutation of MMR genes in either parasite resulted
in the expected enhanced survival in the presence of this alkylating drug.
To ask how the loss of the MMR genes affects the response of T. brucei and T. cruzi cells to
oxidative stress, we compared growth of the WT cells and mutants in the presence of H2O2,
again determining survival in the presence of the damaging agent relative to undamaged cells.
In striking contrast to our previous observations in T. brucei, which showed that Tbmsh2-/-
BSF cells are more susceptible to H2O2 [38], PCF T. brucei msh2mutants were more resistant
to H2O2 than WT cells after 48 hrs growth at either 10 μM or 20 μM (Fig 3A): improved sur-
vival was seen in both themsh2+/- andmsh2-/- cells at this time point, and was also observed
24 and 72 hrs post-treatment (S5 Fig). In contrast, though T. brucei mlh1+/- mutants displayed
a modest increase in H2O2 resistance (in particular upon treatment with 10 μMH2O2; Fig 3A),
mlh1-/- mutants displayed no detectable difference fromWT, indicating that the MMR
response to H2O2 damage is predominantly mediated through MSH2 and not MLH1. This sep-
aration in function between the two MMR factors is consistent with observations in T. brucei
BSF cells, though with distinct patterns of H2O2 sensitivity [38]. Analysis of the T. cruzi epi-
mastigote mutants revealed that loss of bothmsh2 alleles also resulted in increased resistance
to H2O2 in these parasite, though loss of onemsh2 allele resulted in increased sensitivity to
75 μMH2O2, which is distinct from T. brucei msh2+/- mutants [38] and consistent with previ-
ous findings [37] (Fig 3B). Taken together, the enhanced survival of PCF T. brucei msh2 null
mutants to H2O2 exposure suggests a life cycle difference in the consequence of this mutation
relative to BSF cells. Moreover, this unexpected phenotype is conserved in epimastigote T.
cruzi msh2 null mutants.
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T. cruzi msh2 null mutants have increased survival in macrophages
To investigate the role of MSH2 in protecting T. cruzi against oxidative stress generated by
host cells, we compared the capabilities of T. cruziWT andmsh2-/-mutants to infect two dif-
ferent cell types: Vero cells and mouse macrophages. Equal numbers of trypomastigotes
derived from Vero cells infected with WT andmsh2-/- mutants were added to cultures of the
two cell types and the numbers of intracellular amastigotes were determined 2 days later by
staining parasite nuclei with DAPI. As shown in Fig 4A, no difference in the number of intra-
cellular amastigotes was observed in Vero cells infected with WT or Tcmsh2-/- parasites.
Fig 2. Susceptibility of T. brucei and T. cruziMMR knockout mutants to N-methyl-N’-nitro-N-
nitrosoguanidine (MNNG). (A) T. bruceiwild type (WT) and procyclic form mutants (Tbmsh2+/-, Tbmsh2-/-,
Tbmlh1+/- and Tbmlh1-/-) were grown in culture medium with 0 μM, 2.5 μM or 5 μMMNNG. Cell density was
measured after 72 hours growth and is plotted as the percentage survival of the MNNG treated cells relative
to untreated cultures. (B) WT T. cruzi epimastigotes and MSH2 mutants (Tcmsh2+/- andmsh2-/-) were grown
in culture medium with 0 μM or 5 μMMNNG. Cell viability was measured after 72 hours and is plotted as the
percentage survival of the MNNG treated cells relative to untreated cultures. Vertical lines indicate standard
deviation. ***p<0.001, **p<0.01, *p<0.05: determined by one-way ANOVA with Bonferroni post-test of
knockout mutants relative to wild type cells.
doi:10.1371/journal.pntd.0003870.g002
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However, infections with each of the three Tcmsh2-/- clonal cell lines resulted in a 3-fold
increase in the number of intracellular amastigotes relative to infection with WT cells in culti-
vated mouse macrophages (Fig 4B). As macrophages generate ROS, through an infection-
induced respiratory burst [6], while Vero cells do not, these infection data appear consistent
with the increased resistance of T. cruzi msh2-/- null mutants to H2O2 treatment (see Fig 3B).
Fig 3. MSH2 knockout mutants are more resistant to oxidative stress generated by H2O2. (A) T. brucei
wild type (WT),msh2+/-,msh2-/-,mlh1+/- andmlh1-/- procyclic form cells were grown in culture medium with
0 μM, 10 μM or 20 μMH2O2. Cell density was measured after 48 hours and plotted as the percentage survival
of the H2O2 treated cells relative to untreated. (B) T. cruzi epimastigote WT,msh2+/- andmsh2-/- cells were
incubated with or without 75 μMH2O2 for 20 minutes in PBS 1x and then allowed to grow in LIT medium for
48 hours, after which cell viability was determined and plotted as percentage survival of the treated cells
relative to untreated. Vertical lines show standard deviation. ***p<0.001, **p<0.01, *p<0.05: determined by
one-way ANOVA with Bonferroni post-test of mutants relative to wild type cells; ns indicates no signifcant
difference.
doi:10.1371/journal.pntd.0003870.g003
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The infection data also indicate that the increased capacity to survive exposure to oxidative
stress is maintained after T. cruzi differentiates into other life cycle stages.
T. brucei and T. cruzi msh2mutants accumulate 8 oxoguanine in their
DNA
The increased resistance to oxidative stress observed in T. brucei PCF cells and T. cruzi epimas-
tigotes after MSH2 mutation could be a direct consequence of the loss of this MMR compo-
nent, or could be due to indirect effects, such as a metabolic adaptation. To begin to address
this, we determined the capacity of mutant cells to limit the accumulation of oxidized bases in
their genome, which can arise from exposure to ROS generated by endogenous parasite metab-
olism or from the host. The primary DNA lesion generated by oxidative damage is 8-oxoG,
which, if not removed by base-excision repair, can be recognized by MMR [26]. We therefore
measured the levels of this oxidized base in the WT andmsh2mutant parasite genomes using
avidin-conjugated FITC and measuring fluorescence [47]. As shown in Fig 5A and 5B, PCF T.
brucei msh2+/- andmsh2-/- mutants each displayed ~2 fold greater fluorescence in their
nuclear DNA (nDNA) and kinetoplast DNA (kDNA) compared with WT cells. These fluores-
cence data indicate that the levels of 8oxoG were no greater in the T. brucei msh2-/- mutants
than in the Tbmsh2+/-mutants, consistent with the observation that the two mutants display
equivalent levels of resistance to H2O2 (Fig 3). In contrast, no difference was observed in the
levels of fluorescence in the nDNA or kDNA ofmlh1mutants related to WT (Fig 5B), a distinc-
tion from T. brucei msh2mutants again consistent with the separation of MMR functions
observed when examining levels of resistance to H2O2. Increased levels of avidin-FITC fluores-
cence were also seen in the nDNA and kDNA of T. cruzi epimastigotemsh2mutants: 1.7 to 1.9
fold increase in fluorescence was seen in the nDNA and kDNA of both Tcmsh2+/- clones and
both Tcmsh2-/- clones examined relative to WT (Fig 5C). These data suggest that loss or reduc-
tion of MSH2 expression (but not MLH1) in PCF T. brucei and in epimastigote T. cruzi results
in the impairment of a pathway involved in the repair of DNA-directed oxidative damage, such
as 8-oxoG. Thus, the increased resistance to H2O2 in the mutants is best explained by an indi-
rect adaptation to cope with oxidative stress following MSH2 mutation.
Fig 4. Assessment of T. cruzi msh2 knockout mutant infectivity in vitro. (A) T. cruzi trypomastigote cells released by Vero cells infected with either WT
or with three cloned cell lines of Tcmsh2-/- mutants were counted and equal numbers were used to infect Vero cells attached to glass coverslips or (B)
cultured intraperitoneal macrophages extracted from BALB/c mice. Graphs show the average number of intracellular parasites counted per 100 cells; vertical
lines denote standard deviation. **p<0.01, *p<0.05: one-way ANOVA with Bonferroni post-test of knockout mutants relative to wild type.
doi:10.1371/journal.pntd.0003870.g004
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Fig 5. 8-oxoguanine (8-oxoG) accumulation in MSH2 knockout cells. FITC-avidin was used to estimate 8-oxoG levels based on the fluorescence
intensity in the nuclear DNA (nDNA) and kinetoplast DNA (kDNA) of T. brucei procyclic forms and T. cruzi epimastigotes. (A) Representative images of FITC-
avidin or DAPI stained T. bruceiWT cells and Tbmsh2+/- or Tbmsh2-/- mutants are shown. (Bar = 1.9 μM) (B) Fluorescence intensity of FITC-avidin signals
were quantified in the nDNA and kDNA using ImageJ software and plotted as arbitrary units; values shown are the average signal from 100WT, Tbmsh2+/-,
Tbmsh2-/-, Tbmlh1+/- or Tbmlh1-/- PCF cells; vertical lines show standard error (SEM). (C) FITC-avidin signal evaluated by the same process in T. cruzi
epimastigote WT cells and inmsh2+/- andmsh2-/- knockout mutants. ***p<0.001: determined by one-way ANOVA with Bonferroni post-test of knockout
mutants relative to wild type; ns indicates no signifcant difference.
doi:10.1371/journal.pntd.0003870.g005
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Functional complementation confirms adaptation following loss of MSH2
in procyclic form T. bruceimutants
In order to test further if H2O2 resistance inmsh2mutants results from an adaptation process
that occurred in insect life stages of T. brucei, we re-expressed MSH2 in both the BSF and PCF
msh2-/- cells, using a previously described construct and conditions [21]. Integration of the
MSH2 re-expression construct was confirmed by PCR (S6 Fig), and southern blot in BSF [21].
Both BSF and PCFmsh2mutants display increased tolerance to MNNG (Fig 2A), and re-
expression of MSH2 in BSFmsh2-/-mutants reverts this tolerance to the levels ofmsh2+/-
mutants [21, 38]. As shown in Fig 6A, re-expressing MSH2 (Tbmsh2-/-/+) in the PCFmsh2-/-
mutants also resulted in levels of MNNG survival similar tomsh2+/- cells. In addition, and as
seen in T. brucei BSF msh2-/-/+ cells [21], PCF msh2-/-/+ cells no longer showed detectable
microsatellite variation in clonal growth assays (S7 Fig). Taken together, these assays indicate
that MMR function can be restored in T. brucei msh2 null mutants in both life cycle stages
after re-introduction of MSH2 into the genome. In contrast, MSH2 re-expression had a differ-
ent outcome for H2O2 sensitivity in the two life cycle stages. When T. brucei PCFmsh2-/-/+
cells were grown in the presence of 10 μM or 20 μMH2O2 for 48 or 72 hrs, there was no signifi-
cant difference in survival relative to themsh2-/- mutants, and survival was significantly differ-
ent from themsh2+/- mutants (Fig 6B). However, in BSF T. brucei, the survival of themsh2-/-/
+ cells (in this case after 48 hrs growth in either 100 or 200 μMH2O2) was indistinguishable
from themsh2+/- cells and significantly greater than themsh2-/- mutants (Fig 6C). Thus,
while re-expression of MSH2 in T. brucei msh2-/- null mutants was able to restore MMR func-
tion in both life cycle stages, the same re-expression was able to revert the increased sensitivity
to H2O2 only in BSFmsh2-/- mutants. In contrast, the increased tolerance to H2O2 observed in
PCF after loss of MSH2 could not be reverted by re-expressing this gene in this life cycle form
of T. brucei. This lack of MSH2 complementation is most simply explained by changes in
expression or function of another factor(s) that allowed PCF MSH2 mutants to cope specifi-
cally with oxidative stress, though we cannot rule out the possibility of this specific phenotypic
difference between BSF and PCF cells arising due to differing levels of MSH2 in the two life
cycle stages and in themsh2-/-/+ re-expressers. As suggested by RNAi data (S8 Fig), the adap-
tation process that may have occurred during the cloning period needed to generate the
msh2-/- mutants requires several generations. When MSH2 expression is abruptly inhibited by
tetracycline induction of siRNA in T. brucei PCF cells, a discernible slowing of growth is
observed as a consequence of the reducedmsh2mRNA expression.
T. brucei and T. cruziMSH2 display nuclear localization
In this study, and in previous work [37], we have shown that deletion ofmsh2 results in
increased levels of 8-oxoG in both the nDNA and kDNA. Indeed, in BSF T. brucei the most
pronounced cell cycle effect of MSH2 loss, which is exacerbated by H2O2 treatment, is the accu-
mulation of cells with reduced amounts of kDNA (evaluated by DAPI staining) [37]. Because
of these findings, and coupled with lack of a detectable kinetoplastid homologue of MSH1 (a
MutS-like factor involved in mitochondrial genome repair, including oxidative damage repair)
[53, 54], we hypothesized that MSH2 could provide a repair function for the trypanosomes’
mitochondrial (kDNA) genome. To test this hypothesis, we expressed T. brucei and T. cruzi
MSH2 as C-terminal fusions with a 12X c-MYC epitope. For T. brucei, MSH2-myc was
expressed from the endogenous locus in both BSF and PCF cells in which the otherMSH2 allele
was deleted; by evaluating MNNG sensitivity, we showed that the epitope tag did not affect the
function of MSH2 in BSF cells (S9 Fig). As shown Fig 7A and 7B, immunolocalization of
MSH2:myc with anti-c-MYC antiserum in T. brucei BSF and PCF cells revealed only a nuclear
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Fig 6. Re-expression of MSH2 in T. brucei msh2 null mutants. (A) Procyclic form (PCF) T. brucei (Tb) wild type (WT), Tbmsh2+/-, Tbmsh2-/- and
Tbmsh2-/- cells in which MSH2 is re-expressed (Tbmsh2-/-/+) were grown in culture medium with 0 μM, 2.5 μM or 5 μMMNNG. Cell density was measured
after 72 hours growth and is plotted as the percentage survival of the MNNG treated cells relative to untreated. (B) PCFWT, Tbmsh2+/-, Tbmsh2-/- and
Tbmsh2-/-/+ cells were grown in culture medium with 0 μM, 10 μM or 20 μMH2O2 and cell density was determined 48 and 72 hours later; growth is shown
percentage survival of the treated cells relative to untreated (C) Growth of wild type bloodstream form (BSF) T. brucei cells was compared to Tbmsh2+/-,
Tbmsh2-/- and Tbmsh2-/-/+ BSF mutants in the presence of 100 μM or 200 μMH2O2 as described above; graph shows survival of the mutants after 48 hours
growth plotting the density of the treated cells as a percentage of the untreated; vertical lines show standard deviation. ***p<0.001, **p<0.001: determined
by one-way ANOVAwith Bonferroni post-test of mutants relative to wild type; ns indicates no significant difference.
doi:10.1371/journal.pntd.0003870.g006
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Fig 7. MSH2 displays nuclear localisation in T. brucei and T. cruzi. Parasites expressing MSH2 C-terminally fused to 12 copies of the MYC epitope were
used for immunolocalization of MSH2 using anti-MYC antiserum. (A) Transfected T. brucei bloodstream forms, (B) T. brucei procyclic forms, (C) T. cruzi
epimastigotes, (D) T. cruzi intracellular amastigote cells inside infected Vero cels and (E) T. cruzi epimastigotes after 20 min treatment with 70μMH2O2 are
shown. Representive images of DAPI staining of DNA, immunoflourescence with anti-MYC antiserum and phase contrast images of parasite cells are shown
together with merged images. (Bars = 2.3 μm).
doi:10.1371/journal.pntd.0003870.g007
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signal. The same nuclear localization was found in T. cruzi epimastigotes expressing MSH2:
myc, as well as in amastigotes obtained after infection of Vero cells (Fig 7C and 7D). No
changes in subcellular localization of the tagged MSH2 protein were observed in T. cruzi epi-
mastigotes expressing MSH2:myc after exposure to H2O2 (Fig 7E) or other genotoxic agents,
such as MNNG and cisplatin.
Discussion
In previous studies we have described the phenotypic effects of deleting both alleles ofMSH2
orMLH1 in T. brucei BSF cells, and the effects of loss of a single allele ofMSH2 in T. cruzi epi-
mastigotes [21, 37]. Here, we provide several new insights into the function of MMR in African
and American trypanosomes. First, we show that genetic ablation of MSH2 or MLH1 is possi-
ble in T. brucei PCF cells, as is MSH2 ablation in T. cruzi epimastigotes. In all cases, loss of
MSH2 results in detectable impairment in MMR, as demonstrated by the increased tolerance
to the alkylator MNNG, a phenotype specifically seen in MMRmutants in other eukaryotes
[55] and in T. brucei BSF cells [21]. Second, we reveal a striking life cycle dependent difference
in the effect of MSH2 ablation in T. brucei: in PCF cells loss of MSH2 results in increased toler-
ance to H2O2, whereas MSH2 loss results in increased sensitivity in BSF cells [38]. The same
increased tolerance is also seen in T. cruzi epimastigote MSH2 mutants, where it impacts on
the capacity of the parasite to grow in ROS-producing host macrophages. Importantly, altered
H2O2 resistance was not observed when T. brucei BSF or PCF cells lacking MLH1 were exam-
ined. Finally, we provide evidence that the increased resistance to H2O2 in T. brucei after loss
of MSH2 is due to a life cycle dependent adaptation in a facet of the cell that is distinct from
MSH2, since re-expression of the protein restores MMR activity in PCF cells but does not alter
the response to H2O2. In contrast, re-expression of MSH2 in T. brucei BSFmsh2-/- mutants
reverts both MMR impairment and H2O2 sensitivity.
Despite the complexity of phenotypes observed after MMRmutation, the findings indicate
a common function of MSH2 in both trypanosomes: in addition to its role as a key component
of MMR, MSH2 is also directly involved in the response to oxidative stress. Since loss of MLH1
did not result in increased resistance to H2O2 in PCF T. brucei, our new data confirms previous
indications from BSF T. brucei [38] that although MSH2 acts in the parasite’s response to oxi-
dative stress, such a role is unlikely to involve execution of MMR on oxidative lesions through
MLH1-directed functions. Indeed, this is supported by the observation that PCF T. brucei
MSH2 mutants, but not MLH1 mutants, display increased levels of 8-oxoG, a known form of
oxidized base damage [56], in their nuclear and mitochondrial genomes. The same accumula-
tion of 8-oxoG is also seen in T. cruzi msh2-/- andmsh2+/- mutants [37], indicating that such
a role for MSH2 is conserved in the two trypanosomes species. Most likely, a separation of
function between MSH2 and MLH1 in this role will also be found in T. cruzi, though this has
not to date been tested. The nature of MSH2’s role in responding the oxidative damage remains
unclear, including whether or not it is limited to acting upon or repairing 8-oxoG. One possi-
bility is that MSH2 acts in conjunction with MSH6 to repair 8-oxoG in DNA, a known activity
of this heterodimer in other eukaryotes that can act independently of downstreamMMR com-
ponents [32]. However, we also observe accumulation of 8-oxoG in the kDNA of T. brucei and
T. cruziMSH2 mutants, consistent with previous descriptions of kDNA loss in T. brucei BSF
msh2-/- mutants [37], and it is not clear that MSH2-6 could direct such a repair role in the
mitochondrion. A broader role for MSH2 in the oxidative stress response might therefore need
to be considered, perhaps related to findings in other eukaryotes that MSH2-6 can act to signal
the presence of various forms of DNA damage, for instance through ATR [57–59]. It remains
puzzling, however, that much of the signaling and wider activities attributed to MSH2-6 in
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other eukaryotes appear to reside in the extended N-terminal domain of MSH6 [59], which is
notably truncated in trypanosomatid MSH6 orthologues [21]. Nonetheless, such a role for
MSH2 perhaps most readily explains the adaptation we propose in T. brucei PCF, but not in
BSF cells after loss of MSH2. PCF T. brucei have active mitochondrial metabolism, unlike BSF,
and therefore greater levels of endogenous ROS, meaning that loss of MSH2 may be more det-
rimental in this life cycle stage [39]. T. cruzi epimastigotes also have an aerobic metabolism
relying on mitochondrial respiration [60], and it is thus tempting to speculate that the same
adaptation most likely occurred during the generation ofmsh2 null mutants in T. cruzi epimas-
tigotes; though we have no direct evidence for such adaptation, the selection of cells lacking
both alleles was notably problematic and necessitated an altered targeting transfection
approach for removing the second allele.
To date, our analysis of the consequences of T. bruceiMMRmutation have only been con-
ducted in vitro, meaning it remains possible that the life cycle differences, and in particular the
proposed PCF adaptation to MSH2 loss, are due to culture conditions rather than environmen-
tal and metabolic changes as the parasite cycles between host and vector. However, we provide
direct evidence that the increased capacity to survive oxidative stress observed in T. cruzi msh2
-/- mutants may reflect challenges faced by this parasite during its life cycle. Although no dif-
ference in infectivity was observed between T. cruziWT cells andmsh2-/-mutants in Vero
cells, macrophages infected with T. cruzi msh2-/-mutants contained almost 3-fold more intra-
cellular amastigotes than macrophages infected with WT parasites. Due to their phagocytic
nature, macrophages naturally produce ROS through the activation of NADPH oxidase during
phagocytosis or by stimulation with a wide range of infective agents [61]. Although ROS are
expected to be involved in pathogen elimination, increasing evidence suggests that ROS pro-
duction actually could enhance T. cruzi infection in macrophages. For instance, it was recently
proposed that oxidative stress mobilizes cellular iron and fuels T. cruzi infection [62, 63]. A
role for ROS as a signalling molecule has also been highlighted in studies with Leishmania,
where low ROS concentrations regulate proliferation and differentiation by modulating the
activity of cellular targets by oxidation [64]. It seems reasonable to assume that MSH2 is part of
the arsenal of functions that trypanosomatid parasites are equipped with to withstand and
detect oxidative stress during their natural life cycles, and the absence of MSH2 can have wider
effects than simply loss of MMR, as reflected in the adaptation we suggest in PCF T. brucei.
What is the nature of the adaptation following MSH2 mutation? Answering this question
is complicated by the multiple potential pathways that might be affected. One possibility is
that loss of MSH2 necessitates the up-regulation of an alternative repair pathway, such as
base excision repair (BER). BER may be an attractive option because it is known to respond
to oxidative stress and, indeed, a DNA glycosylase termed OGG1 is found in many organisms
[65–67], including T. cruzi [68], that acts on 8-oxoG. However, increased BER activity seems
incompatible with the increased levels of 8 oxoG we detect in T. brucei and T. cruziMSH2
mutants. These data indicate that increased oxidative damage to nucleic acids occurs in the
mutants and therefore suggests that the cells might adapt by limiting their exposure to oxida-
tive stress in other ways. Trypanosomes have a complex set of enzymes involved in the oxida-
tive stress response. One such pathway distinct from the mammalian host is based on
trypanothione metabolism [69]. A paradox in our study is that we can only find evidence for
a nuclear localization of MSH2, even after exposure to H2O2. Most oxidative damage is likely
to occur in the trypanosome mitochondrion, as this is the major source of ROS. However, if
MSH2 is limited to the nucleus, then how does loss of MSH2 result in (as noted above)
increased levels of 8 oxoG in the kDNA? Moreover, if even some of the adaptation we see
after loss of MSH2 affects trypanothione metabolism, then how is the loss of a nuclear protein
communicated to these enzymes, which are thought to be mitochondrial or cytoplasmic
MSH2 Is Associated with Oxidative Stress Response
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0003870 June 17, 2015 20 / 27
[70–74]? One possibility is that C-terminal tagging impairs mitochondrial localization or
MSH2 function. In BSF cells, we can rule this out because MSH2-myc was shown to be func-
tional in the response to MNNG treatment (S9 Fig). However, the same analysis has not been
conducted in PCF T. brucei, where perhaps mitochondrial localization is more important or
pronounced. An alternative explanation is that trypanosome MSH2, perhaps in conjunction
with MSH6, does indeed provide a role in signaling damage, similar to the activities detailed
in other eukaryotes. Whether such signaling is limited to oxidative damage is unknown, but
the signal provided by MSH2 may be communicated, in ways still to be determined, beyond
the nucleus. Hence, if MSH2 is ablated, this element of the signaling cascade is lost. In the
insect stages of at least T. brucei this loss is more deleterious than in the mammal, necessitat-
ing the selection for metabolic adaptation to deal with an altered oxidative stress response,
with the consequence that the mutant becomes more resistant to ROS. The same hypothesis
applies to T. cruzi since similar phenotypic changes were also seen in T. cruzi epimastigote
MSH2 null mutants.
Clearly, further studies will be needed to understand how the parasites adapt to MSH2
mutation and it may be that metabolomic or proteomic approaches are the best strategies to
take, in particular if no compensatory genetic changes followMSH2mutation. Nonetheless,
this work reveals surprising complexity in the outcome of mutation to a core DNA repair path-
way, suggesting interconnections with other cellular pathways. In addition, this study poten-
tially reveals life cycle-dependent differences in MMR function. Loss of BRCA2 has also been
shown to have different effects on genome stability in T. brucei BSF and PCF cells [75], but the
extent to which the wide range of DNA repair pathways in trypanosomatids can vary in their
activity or use through the life cycle remains little explored.
Supporting Information
S1 Fig. Strategy to knockoutMSH2 orMLH1 in T. brucei and T. cruzi. (A) T.brucei (Tb)
MSH2 orMLH1 genes were deleted by replacement of the coding sequence (CDS) of the gene
with a DNA construct that consisted of Puromycin (PURR) or Blasticidin (BSDR) resistance
genes flanked by processing sequences (providing signals for splicing and poliadenylation)
derived from the αβ tubulin intergenic regions. Homologous integration was guided by 5’ and
3’ UTR sequences of either gene that surrounded the antibiotic resistance cassettes. The two
alleles of T.cruzi MSH2 were each deleted by homologous recombination using different DNA
constructs. The first allele was deleted by using 5’ and 3’ UTR sequences to guide integration of
the CDS for the Hygromycin resistance gene (HygroR); in this case, splicing and polyadenyla-
tion of the resistance gene is assumed to be derived from endogenous MSH2 processing signals.
For the second allele, the CDS was not deleted in its entirety, but instead it is was partly deleted
by a construction containing a Neomycin resistance gene (NeoR) flanked by splicing and polya-
denylation signal sequences derived fromHX1 and GAPDH intergenic regions containing sig-
nals for splicing and poliadenylation. Integration of the resistance cassette here is guided by 5’
and 3’MSH2 CDS sequence. (B) A PCR screen to identify double knockout clones (-/-) in
which both alleles of TcMSH2 have been targeted was conducted with specific primers anneal-
ing in the HygroR or NeoR resistance genes together with common primers that recognised
sequences that flanked the MSH2 fragment included in the the constructs. An agarose gel is
shown of the PCR products generated using genomic DNA from T. cruzi wild type cells (WT),
first allele mutant clones (cl1 and cl2 +/-) in which HygroR has been integrated, or double allele
mutants (cl1 and cl2 -/-) in which both HygroR and NeoR have integrated. c- indicates a control
reaction without any input genomic DNA.
(TIF)
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S2 Fig. Assessing the integration of DNA constructions to delete both TbMSH2 and
TbMLH1 alleles. PCR amplifications were carried out to verify the knockout of both TbMSH2
(A) or TbMLH1 alleles (B) using specific primers annealing in the target gene or the PURR or
BSDR resistance genes together with common primers that recognised sequences that flanked
the MSH2 or MLH1 fragment included in the the constructs. Arrows shown in the above pan-
els denote regions of the wild type or mutated loci complementary to the different primers.
PCR products generated using genomic DNA from T. brucei wild type cells (WT), PUR mutant
clones (Tbmsh2/Tbmlh1 +/-) in which PURR has been integrated, BSD mutant clones
(Tbmsh2/Tbmlh1 +/-) in which BSDR has been integrated or double allele mutants (Tbmsh2/
Tbmlh1-/-) in which both PURR and BSDR have integrated are shown after separation on aga-
rose gels.
(TIF)
S3 Fig. Wild type T. cruzi epimastigotes and MSH2 knockout mutants have no difference
in cell growth in vitro.WT T. cruzi epimastigote and two clonal cell lines with one (Tcmsh2
+/-) or bothmsh2 alleles disrupted (Tcmsh2-/-) were diluted in LIT medium to 1x107 parasites.
mL-1 and grown for additional 3 days. Cell densities were measured at 24 hours intervals; bars
indicate standard deviation.
(TIF)
S4 Fig. Microsatellite instability in T. brucei MMR knockouts. PCR amplification of the
microsatellite locus JS2 from PCFWT, Tbmsh2+/-, Tbmsh2-/-, Tbmlh1+/-, and Tbmlh1-/-
grown in the absence (-) and presence (+) of 20μMH2O2 for 48 hours and then cloned by lim-
iting dilution in 96 well culture dishes. The JS2 locus was amplified from 10 clones from each
cell line using primers JS2A and JS2B [21]. PCR products were separated on 3% agarose gesl;
note, the two alleles of this JS2 locus have distinct sizes. PCR product from one of the wild type
sub clones was also added in the first and last lane parallel to the mutants, for size comparison.
Clones that show a difference in size relative to WT are indicated by an arrow; size markers are
shown.
(TIF)
S5 Fig. MSH2 knockout mutants in T. brucei are more resistant to oxidative stress gener-
ated by H2O2 at different time points. T. brucei wild type (WT),msh2+/-,msh2-/-,mlh1+/-
andmlh1-/- procyclic form cells were grown in culture medium with 0 μM, 10 μM or 20 μM
H2O2. Cell density was measured after 24 and 72 hours and plotted as the percentage survival
of the H2O2 treated cells relative to untreated; vertical lines show standard deviation.
p<0.001, p<0.001, difference between mutants relative to wild type.
(TIF)
S6 Fig. Reintegration ofMSH2 in T. brucei procyclic form (PCF)msh2-/-mutants. The
upper diagram shows that the gene knockout strategy deletes the entire TbMSH2 ORF and
indicates the position of primers (‘ORF’) used to test for the presence or absence ofMSH2ORF
in genomic DNA of wild type (WT) cells, Tbmsh2+/- and Tbmsh2-/- mutants, and in three
PCF Tbmsh2-/-/+ clones (1–3) in which theMSH2ORF was reintegrated into the endogenous
locus of the-/- mutant using a construct described previously [21]. The lower diagram shows
two agarose gels, the uppermost displaying PCR products generated using the ORF primers
and the different cells, relative to a control PCR (lower gel) in which the unalteredMSH2 5’
UTR was PCR-amplified (‘UTR’); size markers are shown (kb).
(TIF)
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S7 Fig. Analysis of JS2 microsatellite instability in T. brucei PCF cells in the presence or
absence of of 20 μMH2O2.WT, Tbmsh2+/-, Tbmsh2-/- and Tbmsh2-/-/+ cells were grown in
the absence (-) or presence (+) of 20 μMH2O2 for 48 hours and then cloned by limiting dilu-
tion in 96 well culture dishes. The JS2 locus was amplified from 10 clones from each cell line
using primers JS2A and JS2B [21] and PCR products were separated on 3% agarose gel; note,
the two alleles of the JS2 locus are distinct sizes and are marked by a dashed red line (‘c’ indi-
cates a control PCR reaction run without genomic DNA). PCR product from one of the
untreated wild type sub clones (wt-) was added in the first and last lane of the gels showing the
mutants, for size comparison. Clones that show a difference in size relative to WT are indicated
by an arrow; size markers are shown (bp).
(TIF)
S8 Fig. RNAi of MSH2 in T. brucei PCF. (A) Growth curve of T. brucei PCF cells in which
RNAi against MSH2 was induced by the presence of tetracycline (Tet+) (2 μg.ml-1) Cell density
was measured every 24 hours over a period of 216 hours and compared between the Tet+ cells
and PCF cells grown in the absence of tetracycline (Tet-).; the cultures were diluted to their
starting density every 72 hours. The graph shows the average cell density of two independent
clones, repeated twice; vertical lines indicate standard error. P<0.001 (B)mRNA levels of
MSH2 and MLH1 were determined in one cloned T. brucei PCF cell line before and after RNAi
induction by quantitative reverse-transcriptase PCR. Total RNA extracted from RNAi-induced
(Tet+) and non-induced (Tet-) T. brucei PCF cells was reverse transcribed and quantified
using GPI8 mRNA as an endogenous control. Error bars are standard deviations for four repli-
cates. P<0.001
(TIF)
S9 Fig. Parasites expressing MSH2:c-myc have a functional protein. T. brucei BSF Tbmsh2
+/- were transfected to express MSH2 C-terminally fused to a c-myc tag (Tbmsh2:myc) and the
MMR efficiency was compared in these cells to T. brucei wild type (WT), Tbmsh2+/- and
Tbmsh2-/- cells after treatment with MNNG. Cells were grown at a starting density of 1 x 105
cells.ml-1 in the presence of increasing concentrations of MNNG (from 0.39 μM—400 μM) in
fluorescence-readable 96 well plates. After 48 hours, Alamar Blue was added to each well and
fluorescence was measured after a further 24 hours of growth. IC50 values were determined
and are shown as the mean of three experiments, with standard deviations indicated by vertical
bars.
(TIF)
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